Therapeutic Resistance to Anti-hormonal Drugs in Breast Cancer
Springer-Verlag New York Inc.
978-1-4020-8525-3 (ISBN)
Written by experts in the subject area, this book covers the molecular details and functional consequences of endocrine resistance in breast cancer with particular emphasis on the future applications of novel drug combinations that may be utilized to circumvent resistance and improve anti-tumour effects. This book represents a timely publication in the field of breast cancer research, providing current knowledge in the area of drug resistance and will be important reading material for clinicians and researchers alike.
Experimental Endocrine Resistance: Concepts and Strategies.- Transcriptional Coactivators and Corepressors in Endocrine Response and Resistance in Breast Cancer.- The Re-Expression of Estrogen Receptor in Estrogen Receptor-Negative Breast Cancer and Restoration of Anti-Estrogen Responses.- The Dark Side of Antihormonal Action in Breast Cancer.- Influence of the Tumour Microenvironment.- Are Stem-Like Cells Responsible for Resistance to Therapy in Breast Cancer?.- HSP90 Inhibition as an Anticancer Strategy: Novel Approaches and Future Directions.- Adverse Features of Acquired Antihormone Resistance and Their Targeting.- Identifying Modifiers of Tamoxifen Sensitivity Using High-Throughput Genetic and Chemical Screens.- Endocrine Resistance in Breast Cancer- Where Are We NowWith Intelligent Combination Therapies?.
Erscheint lt. Verlag | 29.1.2009 |
---|---|
Zusatzinfo | XII, 204 p. |
Verlagsort | New York, NY |
Sprache | englisch |
Maße | 155 x 235 mm |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie |
Medizinische Fachgebiete ► Radiologie / Bildgebende Verfahren ► Radiologie | |
Medizin / Pharmazie ► Studium | |
ISBN-10 | 1-4020-8525-7 / 1402085257 |
ISBN-13 | 978-1-4020-8525-3 / 9781402085253 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich